Skip to main content
OpenTrials
Completed

NCT Number: NCT05494944

Low Power ThULEP for Prostate Size More Than 80 gm

Feasibility and Efficacy of lower power thulium enucleation of prostate more than 80 grams

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Samer Morsy

Cairo, 12334, Egypt

About this study

Intra operative outcome and postoperative follow up of IPSS score and IEFF score at 6 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BPH patients with failed medical treatment
  • Refractory retention
  • Hematuria
  • Bladder stones
  • Renal impairment due to BPH

Exclusion criteria

  • Neurogenic patients
  • stricture urethra

Treatment and study plan

ThuLEP

Procedure

Minimal invasive prostate intervention

Primary outcomes

  1. Timing of complete adenoma removal ( enucleation time in minutes)

    Time frame: During operation

  2. International prostate symptoms score IPSS less than 7 which is good outcome

    Time frame: 12 months

Secondary outcomes

  1. International Index of Erectile Function- 5 score more than 12 which is a good outcome

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Kasr El Aini Hospital

Other

Registry information

Official study title

Low Power Thulium Enucleation of Prostate More Than 80 Grams

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Aug 10, 2022
Registry last updated
Aug 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.